Solid Dispersion Strategies for Enhanced Drug Solubility

Solid dispersions are widely employed to address the poor aqueous solubility of novel chemical entities, thereby improving dissolution rate and bioavailability. These systems involve dispersion of an active pharmaceutical ingredient within a carrier matrix, often transforming the drug into an amorphous state to enhance apparent solubility. Strategies include hot-melt extrusion, spray drying and co-precipitation techniques, each tailored to achieve physical stability, sustained supersaturation and controlled release. Advances in polymer selection and process design have enabled fine control over drug–carrier interactions, morphology and release kinetics. Emerging approaches such as phase-separated polymer blends and additive manufacturing are further expanding the toolkit for designing solid dispersions with optimised performance and manufacturability, with broad implications for oral dosage forms ranging from immediate release to sustained-delivery formulations.

Research from Nature Portfolio

Recent studies have employed phase-separated polymer blends to tailor drug release profiles via controlled morphology. By combining hydrophobic and hydrophilic polymers, researchers have elucidated how discrete polymer domains influence pore formation and dissolution channels, revealing correlations between domain architecture, drug distribution and release kinetics through advanced X-ray imaging and dissolution assays. Another line of enquiry utilises fused deposition modelling to generate amorphous solid dispersions via hot-melt extrusion of drug-loaded filaments. Processing parameters such as shell number and infill density were shown to govern the degree of drug amorphisation, mechanical integrity and floating behaviour, leading to enhanced dissolution rates and prolonged gastric residence. These efforts underscore the potential of morphology-driven and 3D-printing approaches for next-generation solid dispersions.

Solid Dispersion Strategies for Enhanced Drug Solubility publication trend

The graph below shows the total number of articles in solid dispersion strategies for enhanced drug solubility across all publications each year (not limited to Nature Index journals).

Technical terms

Amorphous solid dispersion: A system in which the drug is dispersed in an amorphous form within a carrier matrix to increase apparent solubility and dissolution rate.

Hot-melt extrusion (HME): A solvent-free process that melts a polymer-drug mixture and forces it through a die to form a homogeneous dispersion.

Spray drying: A solvent-based technique where a solution or suspension is atomised into hot gas, rapidly producing dry powder particles containing dispersed drug.

Polymeric carrier: A polymer matrix designed to stabilise amorphous drugs, inhibit crystallisation and modulate release kinetics in solid dispersions.

Phase separation: The thermodynamic segregation of polymer components within a blend, leading to distinct domains that can channel drug release upon dissolution.

References

1. Phase-separated polymer blends for controlled drug delivery by tuning morphology. Communications Materials (2024).
2. Fused Deposition Modeling (FDM) 3D Printed Tablets for Intragastric Floating Delivery of Domperidone. Scientific Reports (2017).
3. Advances in the development of amorphous solid dispersions: The role of polymeric carriers. Asian Journal of Pharmaceutical Sciences (2023).
4. Overview of the Manufacturing Methods of Solid Dispersion Technology for Improving the Solubility of Poorly Water-Soluble Drugs and Application to Anticancer Drugs. Pharmaceutics (2019).
5. Mechanisms of increased bioavailability through amorphous solid dispersions: a review. Drug Delivery (2019).